Calgary plays a critical role in Canada’s pharmaceutical sector, which is projected to show substantial market growth in upcoming years. Currently predicted to hit $ 21.37 billion USD within the decade, the Canadian pharmaceutical industry is led by oncology drugs, which account for close to $4 billion USD alone. Calgary boasts a deep and highly educated workforce, which supports innovation in pharmaceutical categories such as neurology and biomechanics.
The companies on this list are the top of the Calgary’s innovative pharmaceutical market.
Pharmaceutical Companies in Calgary to Know
- Path Therapeutics
- Providence Therapeutics
- PurposeMed
- Oncolytics Biotech
- Nimbus Science
- Fluid Biomed Inc.
Pharmaceutical Companies in Calgary
PurposeMed is a digital healthcare and pharmaceutical provider that focuses on providing care to marginalized and otherwise underserved communities. These populations, which struggle to access needed pharmaceutical products, are served via the company’s virtual care paradigms. One of its pharmaceutical intervention areas is in HIV prevention, for which it operates a preventative care platform that focuses on providing PrEP drugs protocols. The company is headquartered in Calgary and hires remotely in Canada.
Path Therapeutics is a neurology technology company that makes therapeutic products for childhood epilepsy. Its work is offered via a digital drug discovery platform known as MitoREAD, which uses neurometabolic metrics to support the identification of novel drug targets. This work informs the development of pharmaceutical and precision medicine products for epileptic patients. The company, founded by a pediatric epileptologist and a pharmacologist, is headquartered in Calgary.
BioAro is a biotechnology company that specializes in precision health through genomics, artificial intelligence and microbiome analysis. Founded in 2021, the company offers whole genome sequencing and related testing services from its head office and lab in Calgary. BioAro provides data-driven health insights for individuals and offers software solutions for healthcare professionals and researchers.
Hemostemix is a clinical-stage biotechnology company developing autologous cell therapies designed to treat ischemic conditions resulting from a lack of blood flow. Founded in 2003, the company is headquartered in Calgary. Its lead product candidate, ACP-01, is a regenerative cell therapy generated from a patient's own blood and is being investigated for its potential to repair and regenerate damaged tissue.
Based in Calgary and founded in 2015, Providence Therapeutics is a clinical healthcare research and development company. It works on novel products such as emerging vaccines and precision oncology. Its product development pipelines are informed by research from its dedicated mRNA discovery platform, which allows scientists to leverage advanced digital technology to increase the speed of drug discoveries.
GSK is a multinational pharmaceutical company with global operations. It functions in numerous locations, including Calgary, via its network of wholly owned subsidiary companies, which perform research, development and manufacturing processes in the company’s name. GSK is a top global provider of vaccinations and therapeutics, with products and research initiatives split into four divisions for oncology, HIV, immunology and respiratory therapies and infectious disease.
Fluid Biomed Inc. is a pharmaceutical technology company that manufactures medical devices for internal use within the human body. Headquartered in Calgary, the company’s products rely on proprietary materials technology in advanced polymers, which are used to form products like brain stents, which are used in the treatment of aneurysms. Polymer is a novel material in this application, and the company was the first to bring a polymer brain stent to market.
Northern RNA is a contract development and manufacturing organization, or CDMO, that provides services for producing nucleic acid products, such as mRNA and DNA. Founded in 2021, the company operates a biomanufacturing facility in Calgary, Alberta. Northern RNA offers end-to-end support for its clients, including construct design, development services and GMP-grade production for therapeutics and vaccines.
Oncolytics Biotech is a late-stage biotechnology company focused on developing pelareorep, an innovative immunotherapy designed to treat a variety of cancers. Its approach uses an intravenously delivered, systemically active agent to make tumors more responsive to other treatments. Headquartered in Calgary, Alberta, the company was founded at the University of Calgary in 1998. It continues to advance its clinical trials from its Canadian base, contributing to the local life sciences ecosystem.
Nimble Science is a precision medicine company. Its research, development and product pipelines focus on the microbiota of the human intestinal tract, with specific focus on the small intestine’s microenvironment of bacteria. The company’s product is a diagnostic capsule that is ingested and tasked with non-invasively gathering data as it passes through the digestive tract. The company is headquartered in Calgary.
